Finder

Current NHS consultant posts held

I am a consultant Neurologist and Clinical Director of Medical Neurosciences at the Manchester Centre for clinical Neuroscience at Salford Royal Foundation Trust.
I also practice at Wythenshawe Hospital, where my clinics are held at Withington Community Hospital.

Research interests

Myasthenia Gravis, Neurological aspects of general medical disease, Design of effective services, Musician’s hand disorders.

Personal interests

When the Mancunian weather is acceptable, I run, cycle and walk on the hills and try to maintain a kitchen garden. At other times I try to learn to play the piano.

Awards received

2010 European Federation of Neurological Societies Investigation Prize awarded to peripheral nerve team at Greater Manchester Neuroscience Centre.

2007 Health Services Journal award for Clinical Service Redesign for Neurological ICATs.

1997 Liversedge Prize awarded by the North of England Neurological Society.

1995 European Neurological Society prize for best scientific paper presented.

1993 Liversedge Prize awarded by the North of England Neurological Society.

Publications

Neurological Manifestations of Haematological Disease. J.D.Sussman, G.A.B. Davies-Jones. Neurology in General Medicine, 5th. Edition, Ed. Aminoff, M.
Bulbar myasthenia gravis: Why are treatable patients needing admission to hospital - Are neurologists doing something wrong? Niestrata-Ortiz M.; Sussman J., Niestrata-Ortiz. European Journal of Neurology 2014; 2141
Antisense Treatment for Myasthenia Gravis: Experience with Monarsen J.D. Sussman, Z. Argov, D. McKee, E. Hazum, S. Brawer, H. Soreq. Annals of the New York Academy of Sciences 2012;1275:13-16
Gregersen PK, Kosoy R, Lee AT, Lamb J, Sussman J, et al. Risk for myasthenia gravis maps to a 151Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08. Annals of Neurology 2012. 72:927-935
Argov, Z., McKee, D., Agus, S., Soreq, H., Ben-Joseph, O., Brawer, S., Sussman, J.D. Oral antisense therapy for acetylcholinesterase suppression in myasthena gravis: Preliminary data on efficacy and safety. Neurology 2007;69:699-700
Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells. K.A. Harkness, J. D. Sussman, G. A. B. Davies-Jones, J. Greenwoode and M. N. Woodroofe. J Neuroimmunology 2003; 142:1-9
Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. K. A. Harkness, J. Greenwood, J. D. Sussman, et al. Brain 2000;123:698-709
Benign Intracranial Hypertension. Sussman JD Sarkies N, Pickard JD. Advances Tech Standards Neurosurg, Springer-Verlag, 1998;24:261-305
Glial lineages and myelination in the central nervous system.
D.A.S. Compston, J. Zajicek, J. Sussman, et al. J Anatomy 1997. 190: 161-200
Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension. J. Sussman, M. Leach, R. Malia, et al. Journal of Neurology, Neurosurgery and Psychiatry 1997. 62: 229-233
Failure to achieve remyelination of demyelinated rat axons following transplant of glial cells obtained from adult human brain. M.P. Targett, J. Sussman, N.J. Scolding, et al. Neuropath Appl Neurobiol 1996. 22: 199-206
A proliferative adult human oligodendrocyte progenitor. N.J. Scolding, P.J. Rayner, J. Sussman, et al. NeuroReport. 1995;6:441-445.
Transplantation of human oligodendrocytes into demyelinating lesions in the rat spinal cord. M.P. Targett, J.D. Sussman, M.T. O’Leary, et al. Neuropathology and Applied Neurobiology, 1995; 21: 446.

Courses offered to GPs

I am always happy to speak to GPs on any common area in General Neurology, either delivering a talk, or an informal discussion based on case histories provided by GPs.